The CURE research team focuses on advancing personalized medicine through the integration of regenerative medicine with precise, non-invasive diagnostics. Our goal is to develop therapeutic and diagnostic solutions tailored to each patient’s individual characteristics, based on reliable biological data and real clinical needs.

The core of the team’s activities involves research on advanced therapy medicinal products (ATMPs), including cell- and extracellular vesicle-based therapies. We develop tissue engineering technologies, including the design and fabrication of grafts for urinary tract reconstruction. Our work is interdisciplinary, combining biotechnology, materials engineering, molecular biology, and clinical practice.

Alongside the development of regenerative therapies, the CURE team conducts research on modern diagnostics for urological cancers. We focus on the identification and validation of extracellular vesicle-based biomarkers, the analysis of their molecular cargo, and metabolomic and volatilomic analyses of urine. This approach enables non-invasive disease monitoring, assessment of treatment effectiveness, and more precise selection of therapeutic strategies.

A key element of the team’s activity is translating research findings into clinical practice. We integrate basic, preclinical, and clinical research into a coherent process aimed at achieving tangible, measurable outcomes: new medicinal products, therapeutic procedures, diagnostic tools, scientific publications, and technologies ready for further implementation. The team’s work is carried out in close collaboration with clinical centers and national and international partners.

The CURE also serves as a platform for the development of young researchers. Students and young scientists are actively involved in research projects, preparation of publications, and applications for external funding. We emphasize transparent collaboration, clearly defined goals, and high research quality standards.

The activities of the CURE team are based on the conviction that effective medicine of the future requires the integration of innovative therapeutic technologies with precise diagnostics and conscious management of the research process. The CURE team is dedicated to developing solutions that genuinely improve treatment quality and support modern, personalized patient care.